Jade Biosciences, Inc. (JBIO) stock
JBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.14+0.27 (+1.70%)
Close on Nov 13, 2026Market cap $1.03BP/E –Yield –
Jade Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Jade Biosciences's enterprise value was $590.01M on Nov 11, 2026, against $219.37M a year earlier. Over the last 5 years it ranged from -$43.71M to $28.61B, with a median of $8.19B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $590.01M | +93.7% |
| 2025 | Dec 31, 2025 | $304.53M | -88.2% |
| 2024 | Dec 31, 2024 | $2.59B | -88.1% |
| 2023 | Dec 29, 2023 | $21.77B | -12.9% |
| 2022 | Dec 30, 2022 | $24.99B | +152.6% |
| 2021 | Dec 31, 2021 | $9.89B | – |
See a number that looks wrong?